Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.1K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bispecific CAR T and CAR NK cells in dual-threat immunotherapy: opportunities and challenges.

Molecular biology reports·2026
Same author

Cathepsin Z/X: Breaking Down the Known and Unknown.

International journal of molecular sciences·2026
Same author

Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressiveness.

Communications medicine·2026
Same author

Decoy Nanoparticles and Protein Corona Modulation: A Novel Frontier in Sepsis Treatment.

International journal of nanomedicine·2026
Same author

From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics.

Asian journal of pharmaceutical sciences·2026
Same author

New Therapeutic Options Against Clinically Relevant Proteases in Cancer Progression.

Mini reviews in medicinal chemistry·2026

Related Experiment Video

Updated: Oct 14, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.3K

BH3-mimetics: recent developments in cancer therapy.

Paul A Townsend1,2,3, Maria V Kozhevnikova4,5, Olivier N F Cexus4

  • 1University of Surrey, Guildford, UK. p.townsend@surrey.ac.uk.

Journal of Experimental & Clinical Cancer Research : CR
|November 10, 2021
PubMed
Summary

BH3-mimetics offer promising therapeutic strategies by targeting apoptosis pathways, particularly in cancer research. These advancements also extend to cardiovascular disease and tissue fibrosis, highlighting their broad impact on homeostasis.

Keywords:
ApoptosisBH-3 mimeticsBcl-xL-mimeticsMcl1-mimeticsNanoparticlesNoxa-mimeticsPUMA-mimeticsSmac-mimetics

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.5K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.2K

Related Experiment Videos

Last Updated: Oct 14, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.3K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.5K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.2K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • BH3-mimetics research has advanced for 30 years, establishing paradigms for targeting apoptosis pathway intermediates.
  • These approaches have yielded therapeutics and provided insights into genetic mechanisms for future research.
  • The impact is significant in cancer research, specifically by targeting BAX-Bcl-2 protein-protein interactions.

Purpose of the Study:

  • To review the development and diversification of BH3-mimetics.
  • To focus on their application in single and combined cancer treatment regimens.
  • To explore novel therapeutic delivery methods for BH3-mimetics.

Main Methods:

  • Literature review of BH3-mimetics research.
  • Analysis of therapeutic applications in various diseases.
  • Examination of cancer treatment strategies and delivery systems.

Main Results:

  • BH3-mimetics have shown success in targeting apoptosis, with significant implications for cancer therapy.
  • Applications have expanded beyond cancer to include cardiovascular disease and tissue fibrosis.
  • Research highlights the importance of the apoptosis pathway in tissue homeostasis.

Conclusions:

  • BH3-mimetics represent a vital class of therapeutics with broad applications.
  • Continued research in BH3-mimetics, including novel delivery methods, holds promise for future treatments.
  • Targeting apoptosis pathways is crucial for managing various diseases and maintaining tissue homeostasis.